BUPIVACAINE HCI
- Product NDC
- 51662-1581
- 11-digit product format
- 516621581
- Labeler code
- 51662
- Product ID
- 51662-1581_0f90b497-04bc-5195-e063-6294a90a2b58
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- BUPIVACAINE HCI
- Dosage form
- INJECTION, SOLUTION
- Route
- INFILTRATION; PERINEURAL
- Labeler
- HF Acquisition Co LLC, DBA HealthFirst
- Application
- ANDA207183
- Marketing category
- ANDA
- Marketing start
- 2022-07-10
- Substance
- BUPIVACAINE HYDROCHLORIDE
- Active strength
- 2.5 mg/mL
- Pharmacologic classes
- Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 7TQO7W3VT8 | BUPIVACAINE HYDROCHLORIDE | 73360-54-0 | BUPIVACAINE HYDROCHLORIDE |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 51662-1581-3 | 51662158103 | 25 POUCH in 1 CASE (51662-1581-3) / 1 VIAL, MULTI-DOSE in 1 POUCH (51662-1581-2) / 50 mL in 1 VIAL, MULTI-DOSE | 25 pouch | 2022-07-10 | No | No | Historical |